Vext Science ( (VEXTF) ) has released its Q3 earnings. Here is a breakdown of the information Vext Science presented to its investors.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Vext Science, Inc. is a U.S.-based cannabis operator with operations in Arizona and Ohio, known for its vertical integration from cultivation to retail and its Vapen™ brand of THC products.
In its latest earnings report, Vext Science announced a significant 41% increase in revenue year-over-year for the third quarter of 2025, reaching $12.7 million. The company also reported a year-to-date operating cash flow of $8.5 million, showcasing strong financial performance driven by its expanding retail operations in Ohio and steady performance in Arizona.
Key financial highlights include a notable improvement in operating cash flow compared to the previous year and the strengthening of its retail presence in Ohio, where it aims to reach the state dispensary license cap by 2026. Despite mixed market dynamics, Vext’s operational discipline has allowed it to outperform state averages in Arizona and maintain a robust cash flow margin.
Looking ahead, Vext Science remains focused on maximizing performance across its Ohio dispensaries and advancing the construction and licensing of additional locations. The company is poised to leverage its vertically-integrated platform to drive sustainable growth and create long-term value for shareholders, according to its management’s outlook.